Stockreport

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis

Telesis Bio, Inc.  (TBIO) 
PDF New technology has potential to accelerate timelines for therapeutic research and drug development SAN DIEGO--(BUSINESS WIRE)--Telesis Bio Inc. (OTCMKTS: TBIO), a lea [Read more]